Non-smoker diagnosed with stage four lung cancer raises awareness.
Natasha Loveridge, a non-smoker from England, was diagnosed with stage four lung cancer in December due to a gene mutation called EGFR+. She is now raising awareness for lung cancer and pushing for a national universal screening program. Loveridge is currently taking a cancer-growth blocking drug called osimertinib, which has already shown a reduction in her primary tumor by 25%. She is also raising money for a lung cancer research charity called Roy Castle Lung Cancer Foundation.